The first half of the year is almost over -- and so far, 2023 has been pretty kind to investors. Broader equity markets bounced back from last year's nightmare while economic pressures, notably inflation, cooled off. Still, some may worry that there are issues ahead, with the possibility of a recession especially high on the list of things that might go wrong before the year ends.

But as always, investors can take solace in the fact that no matter what transpires in the next six months, equity markets will generally continue on an upward path in the long run. Buying shares of the right companies can help investors' portfolios do the same.

With that said, let's consider two stocks worth investing in regardless of what lies ahead: Regeneron Pharmaceuticals (NASDAQ: REGN) and Microsoft (NASDAQ: MSFT).

Continue reading

Source Fool.com